{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:29:59Z","timestamp":1789777799429,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.tracli.2022.11.007","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:28:33Z","timestamp":1670358513000},"page":"212-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The appropriateness of platelet transfusions in hematological patients and the potential for improvement"],"prefix":"10.1016","volume":"30","author":[{"given":"Milica","family":"Liker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ba\u0161i\u0107 Kinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadira","family":"Durakovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Bojani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Aurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Golubi\u0107 \u0106epuli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2022.11.007_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/trf.16134","article-title":"Evaluating the appropriateness of platelet transfusions compared with evidence\u2010based platelet guidelines: an audit of platelet transfusions at 57 hospitals","volume":"61","author":"Hill\u2010Strathy","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2022.11.007_b0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/tme.12126","article-title":"Where did platelets go in 2012? a survey of platelet transfusion practice in the North of England","volume":"24","author":"Charlton","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2022.11.007_b0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tracli.2021.08.004","article-title":"Platelet transfusion practice and related transfusion reactions in a large teaching hospital","volume":"29","author":"Liker","year":"2022","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2022.11.007_b0020","first-page":"10983","article-title":"Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation","volume":"2015","author":"Estcourt","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tracli.2022.11.007_b0025","doi-asserted-by":"crossref","unstructured":"Yuan S, Yang D, Nakamura R, Zhuang L, al Malki MM, Wang S. RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation. Transfusion (Paris) 2019;59:3371\u201385. https:\/\/doi.org\/10.1111\/TRF.15531","DOI":"10.1111\/trf.15531"},{"key":"10.1016\/j.tracli.2022.11.007_b0030","article-title":"Platelet transfusion in adults: an update","author":"Garraud","year":"2022","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2022.11.007_b0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2022.11.007_b0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1200\/JOP.2017.028902","article-title":"Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary","volume":"14","author":"Schiffer","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.tracli.2022.11.007_b0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tracli.2022.11.007_b0055","unstructured":"Petraszko T, Zeller M. PLATELET TRANSFUSION, ALLOIMMUNIZATION AND MANAGEMENT OF PLATELET REFRACTORINESS 2018. https:\/\/professionaleducation.blood.ca\/en\/transfusion\/clinical-guide\/platelet-transfusion-alloimmunization-and-management-platelet"},{"key":"10.1016\/j.tracli.2022.11.007_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tmrv.2014.11.004","article-title":"Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia","volume":"29","author":"Nahirniak","year":"2015","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2022.11.007_b0065","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.1997.15.3.1143","article-title":"Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000\/microL versus 20,000\/microL","volume":"15","author":"Heckman","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tracli.2022.11.007_b0070","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A No-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2022.11.007_b0075","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2022.11.007_b0080","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2022.11.007_b0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1537-2995.2007.01090.x","article-title":"Evaluation of platelet transfusion triggers in a tertiary-care hospital","volume":"47","author":"Cameron","year":"2007","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2022.11.007_b0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1537-2995.2007.01089.x","article-title":"Platelet utilization and the transfusion trigger: a prospective analysis","volume":"47","author":"Greeno","year":"2007","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2022.11.007_b0095","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1445-5994.2010.02358.x","article-title":"An audit of platelet transfusion within the Wellington Cancer Centre","volume":"42","author":"Buhrkuhl","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.tracli.2022.11.007_b0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/vox.12550","article-title":"Audit of appropriate use of platelet transfusions: validation of adjudication criteria","volume":"113","author":"Etchells","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2022.11.007_b0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1423-0410.2012.01627.x","article-title":"Platelet transfusions in haematology patients: are we using them appropriately?","volume":"103","author":"Estcourt","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2022.11.007_b0110","doi-asserted-by":"crossref","first-page":"e013483","DOI":"10.1136\/bmjopen-2016-013483","article-title":"Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study","volume":"6","author":"Tay","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.tracli.2022.11.007_b0115","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/trf.16816","article-title":"Changes in the incidence of transfusion reactions in hematological patients over the past 30 years","volume":"62","author":"Bojani\u0107","year":"2022","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2022.11.007_b0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/tme.12331","article-title":"Effective implementation of a patient blood management programme for platelets","volume":"26","author":"Sekhar","year":"2016","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2022.11.007_b0125","unstructured":"Friedman MT. PATIENT BLOOD MANAGEMENT IN HEMATOLOGY AND ONCOLOGY 2020. https:\/\/www.aabb.org\/docs\/default-source\/default-document-library\/resources\/pbm-in-hematology-and-oncology.pdf?sfvrsn=21725df9_2"},{"key":"10.1016\/j.tracli.2022.11.007_b0130","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1111\/trf.15414","article-title":"Implementation of a patient blood management program in hematopoietic stem cell transplantation (Editorial, p. 2763)","volume":"59","author":"Warner","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2022.11.007_b0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.21037\/aob-20-30","article-title":"Platelet transfusion in the real life","volume":"5","author":"Solves","year":"2020","journal-title":"Ann Blood"},{"key":"10.1016\/j.tracli.2022.11.007_b0140","unstructured":"2017 Repeat Audit of Red cell and Platelet Transfusion in Adult Haematology Patients n.d. https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/14912\/report_26007737.pdf"},{"key":"10.1016\/j.tracli.2022.11.007_b0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tmrv.2004.03.003","article-title":"Relationship between platelet count and bleeding risk in thrombocytopenic patients","volume":"18","author":"Slichter","year":"2004","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2022.11.007_b0150","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/j.1537-2995.2010.02757.x","article-title":"The appropriateness and physician compliance of platelet usage by a computerized transfusion decision support system in a medical center","volume":"50","author":"Lin","year":"2010","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2022.11.007_b0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.transci.2013.11.009","article-title":"A retrospective audit of platelet transfusion in a hematology service of a tertiary-care hospital: effectiveness of training to improve compliance with standards","volume":"50","author":"Solves","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2022.11.007_b0160","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell\u2019Adulto","volume":"337","author":"Rebulla","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2022.11.007_b0165","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1537-2995.2005.04157.x","article-title":"A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients","volume":"45","author":"Diedrich","year":"2005","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2022.11.007_b0170","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1182\/blood-2004-05-1841","article-title":"The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study","volume":"105","author":"Senseb\u00e9","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2022.11.007_b0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1537-2995.1973.tb05490.x","article-title":"Prophylactic platelet transfusions in children with acute leukemia: a dose response study","volume":"13","author":"Roy","year":"1973","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2022.11.007_b0180","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2008-09-178236","article-title":"A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia","volume":"113","author":"Heddle","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2022.11.007_b0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.transci.2015.03.008","article-title":"The utility of thromboelastometry in prophylactic platelet transfusion for hematological malignancies","volume":"53","author":"Akay","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2022.11.007_b0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood.V112.11.285.285","article-title":"Effects of prophylactic platelet (Plt) dose on transfusion (Tx) outcomes (PLADO trial)","volume":"112","author":"Slichter","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2022.11.007_b0195","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.0041-1132.2004.04118.x","article-title":"Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design","volume":"44","author":"Tinmouth","year":"2004","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2022.11.007_b0200","doi-asserted-by":"crossref","unstructured":"Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P, et al. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2015;2015. https:\/\/doi.org\/10.1002\/14651858.CD010984.PUB2","DOI":"10.1002\/14651858.CD010984.pub2"},{"key":"10.1016\/j.tracli.2022.11.007_b0205","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1111\/trf.13848","article-title":"Improving transfusion practice with guidelines and prospective auditing by medical laboratory technologists","volume":"56","author":"Lin","year":"2016","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tracli.2022.11.007_b0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/vox.13132","article-title":"A randomized study of a best practice alert for platelet transfusions","volume":"117","author":"Murphy","year":"2022","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2022.11.007_b0215","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tracli.2008.01.002","article-title":"National comparative audit of the use of platelet transfusions in the UK","volume":"14","author":"Qureshi","year":"2007","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2022.11.007_b0220","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/trf.16257","article-title":"Quality of evidence-based guidelines for platelet transfusion and use: a systematic review","volume":"61","author":"Al\u2010Riyami","year":"2021","journal-title":"Transfusion (Paris)"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782022003482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782022003482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:40:23Z","timestamp":1761129623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782022003482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1246782022003482"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2022.11.007","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The appropriateness of platelet transfusions in hematological patients and the potential for improvement","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2022.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}